What we do:
Mundipharma EDO GmbH (EDO) is a company focused on the preclinical and clinical development of treatments for cancer types where there are currently limited options for patients. EDO collaborates with a worldwide network of clinical connections and experienced partners. The company is currently researching treatments for haematological malignancies, solid tumours (including biliary tract cancer) and CNS tumours. Find out more about the EDO ethos and model here.